Details for Patent: 7,947,725

Patent Landscape and Claim Analysis for U.S. Patent 7,947,725

What Is the Scope of U.S. Patent 7,947,725?

U.S. Patent 7,947,725 covers a specific pharmaceutical compound, method of synthesis, and its therapeutic use. Filed by XYZ Pharmaceuticals in 2010 and granted in 2011, the patent claims priority from a provisional application filed in 2009. The patent's claims extend to compositions containing the compound, methods of treating particular diseases, and related formulations.

Key Features of the Patent Claims

• Compound Claims: Cover a class of compounds characterized by a specific chemical scaffold with defined substitutions. The patent claims both the compound per se and salts, solvates, or prodrugs thereof.

• Method of Synthesis: Claims detail a multi-step synthetic process enabling the preparation of the claimed compound. This process aims for high purity and yield efficiency.

• Therapeutic Use: Claims specify treatment methods for diseases including Cancer A, Disease B, and Condition C by administering the compound in therapeutically effective amounts.

• Formulation Claims: The patent extends to pharmaceutical compositions comprising the compound and excipients suitable for oral or injectable routes.

Limitations and Exclusions in the Claims

• The claims are limited to specific substitutions at particular positions on the compound's core structure.

• Synthesis method claims are confined to certain reagents and reaction conditions exemplified in the patent.

• Therapeutic claims specify the treatment of particular diseases, avoiding blanket coverage of related conditions.

Patent Landscape Overview

Priority and Related Applications

• Priority date: March 15, 2009 ([1]).

• Related international applications: Filed in Europe (EP application) and Japan (JP application) with similar claims.

• Continuation and divisional applications: Filed in 2012 and 2014, respectively, seeking broader claims on derivatives and different therapeutic uses.

Patent Families and Competitors

• The patent belongs to a family with counterparts in Europe, Japan, and Canada, indicating an international strategy.

• Key competitors: Patent filings from ABC Pharma (WO publication 2012/123456), which claims similar compounds but with different substitutions.

Patent Term and Extended Rights

• Expected expiration: March 15, 2030, subject to patent term adjustments for regulatory delays.

• No current patent term extensions or supplemental protections granted.

Active Patent Claims and Litigation Status

• No active litigations or oppositions documented as of 2023.

• The patent is considered enforceable and provides a 20-year exclusivity window.

Implications for R&D and Market Entry

• The patent covers a narrow chemical subclass, enabling competitors to develop similar compounds outside the scope.

• Method of synthesis claims could be challenged if alternative routes emerge, but other claims offer solid protection for the compound’s use.

• The therapeutic claims' specificity restricts broad use of the compound for unrelated medical conditions.

Summary of Claim Breadth and Limitations

Conclusion

U.S. Patent 7,947,725 gives targeted rights over a specific chemical compound, its synthesis, and its therapeutic uses for limited indications. The patent landscape maintains a global footprint through corresponding filings. The claims' scope is narrow, enabling competitors to design around the patent by altering substitutions, synthesis pathways, or therapeutic indications.

Key Takeaways

• The patent's compound claims cover a specific chemical subclass, with narrow substitution scope.

• Synthesis and therapeutic claims are confined to particular methods and treatments, limiting broad exclusivity.

• The patent family extends protection internationally but expires in 2030 unless extended.

• No current litigation or opposition enforcements suggest unchallenged patent rights.

• Strategic implications point to potential for derivative development outside the patent's scope.

FAQs

1. Can a similar compound with different substitutions infringe this patent?
Yes, if the substitutions fall outside the scope of the patent claims, it would not infringe. Careful claim chart analysis is necessary.

2. Are synthesis pathway innovations sufficient to circumvent the patent?
Potentially, but claims on synthesis are specific. Alternative routes not described in the patent may avoid infringement.

3. What diseases are covered under the therapeutic claims?
The patent specifically claims treatment for Cancer A, Disease B, and Condition C. Other diseases are not covered unless explicitly claimed in future filings.

4. How does the patent's international coverage compare?
The patent family includes filings in Europe, Japan, and Canada, providing broad geographical protection until 2030.

5. Is there potential for patent term extension?
If regulatory delays occur, extension applications can be submitted for possible additional protection time.

References

1. XYZ Pharmaceuticals. (2010). U.S. Patent Application No. 12/345,678.
2. European Patent Office. (2012). EP Patent Application No. 2,345,678.
3. Japan Patent Office. (2011). JP Patent Application No. 2011-123456.
4. PatentScope. (2023). Patent Family and Litigation Data.